JPRN-UMIN000020935已完成未知
A prospective study for the effect of ferric citrate on FGF23 in patients with normophosphatemic CKD patients with iron deficiency. - the effect of ferric citrate on FGF23
Department of Nephrology and Rheumatology, Saiseikai Niigata Daini Hospital0 个研究点目标入组 60 人开始时间: 2016年2月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)treatment with phosphate binder or iron supplementation 2) hypersensitivity to lanthanum carbonate and calcium carbonate 3) pregnancy or lactation 4) Any reason for ineligibility suggested by the attending doctor
研究者
相似试验
已完成
不适用
Clinical evaluation of the effect of ferric citrate hydrate in hemodialysis patients with renal anemia and hyperphosphatemiaJPRN-UMIN000025478Saiseikai Kumamoto Hospital80
已完成
不适用
Exploratory study to evaluate effect of ferric citrate hydrate on oxidative-stress in maintenance hemodialysis patients.Maintenance hemodialysis patientsJPRN-UMIN000020702Fukushima Medical University6
已完成
不适用
Effects and safety of ferric citrate hydrate in patients with receiving hemodialysis.Chronic hemodialysis patientsJPRN-UMIN000028669Tomei-Atsugi Hospital30
已完成
不适用
The efficacy of ferric citrate hydrate in chronic kidney disease with mild hyperphosphatemia: randomized controlled open-labeled trialpredialysis chronic kidney disease (predialysis CKD)JPRN-UMIN000018118Osaka Medical College, department of Internal Medicine 340
已完成
不适用
A multicenter switching study to ferric citrate hydrate for treatment of iron deficiency anemia in patients with intolerance to previous oral iron preparation (RIO-SWITCH)Iron-Deficiency AnemiaJPRN-jRCTs031210634Osuga Yutaka30